» Articles » PMID: 36544988

Apathy and in Mild Behavioral Impairment, and Risk for Incident Dementia

Overview
Date 2022 Dec 22
PMID 36544988
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Mild behavioral impairment (MBI) is a high-risk state for incident dementia and comprises five core domains including affective dysregulation, impulse dyscontrol, social inappropriateness, psychotic symptoms, and apathy. Apathy is among the most common neuropsychiatric symptoms (NPS) in dementia but can also develop in persons with normal cognition (NC) or mild cognitive impairment (MCI). The later-life emergence and persistence of apathy as part of the MBI syndrome may be a driving factor for dementia risk. Therefore, we investigated MBI-apathy-associated progression to dementia, and effect modification by sex, race, cognitive diagnosis, and apolipoprotein E () genotype.

Methods: Dementia-free National Alzheimer's Coordinating Center participants were stratified by persistent apathy status, based on Neuropsychiatric Inventory (NPI)-Questionnaire scores at two consecutive visits. Hazard ratios (HRs) for incident dementia for MBI-apathy and NPI-apathy relative to no NPS, and MBI-apathy relative to no apathy, were determined using Cox proportional hazards regressions, adjusted for baseline age, sex, years of education, race, cognitive diagnosis, and genotype. Interactions with relevant model covariates were explored.

Results: Of the 3932 participants (3247 with NC), 354 had MBI-apathy. Of all analytic groups, MBI-apathy had the greatest dementia incidence (HR = 2.69, 95% confidence interval [CI]: 2.15-3.36,  < 0.001). Interaction effects were observed between cognitive diagnosis and genotype with the NPS group. The contribution of apathy to dementia risk was greater in NC (HR = 5.91, 95% CI: 3.91-8.93) than in MCI (HR = 2.16, 95% CI: 1.69-2.77, interaction  < 0.001) and in all genotypes, was greatest in ɛ3 (HR = 4.25, 95% CI: 3.1-5.82, interaction  < 0.001).

Discussion: Individuals with MBI-apathy have a markedly elevated risk for future dementia, especially when symptoms emerge in those with NC. Both cognitive status and genotype are important moderators in the relationship between MBI-apathy and incident dementia. MBI-apathy may represent a group in whom apathy is a preclinical or prodromal manifestation of dementia and identify a precision medicine target for preventative interventions.

Citing Articles

Menopausal symptom burden as a predictor of mid- to late-life cognitive function and mild behavioral impairment symptoms: A CAN-PROTECT study.

Crockford J, Guan D, Einstein G, Ballard C, Creese B, Corbett A PLoS One. 2025; 20(3):e0301165.

PMID: 40043017 PMC: 11882070. DOI: 10.1371/journal.pone.0301165.


GWAS links to neuropsychiatric symptoms in mild cognitive impairment and dementia.

Vattathil S, Blostein F, Miller-Fleming T, Davis L, Wingo T, Wingo A medRxiv. 2025; .

PMID: 39974048 PMC: 11838693. DOI: 10.1101/2025.01.31.25321498.


Mild behavioral impairment in the general population aged 55+ and its association with incident dementia.

Gracia-Garcia P, Lopez-Anton R, De la Camara C, Santabarbara J, Lobo E, Lobo A Alzheimers Dement (Amst). 2024; 16(4):e12610.

PMID: 39391020 PMC: 11465024. DOI: 10.1002/dad2.12610.


Neuropsychiatric symptoms: Risk factor or disease marker? A study of structural imaging biomarkers of Alzheimer's disease and incident cognitive decline.

Guan D, Rehman T, Nathan S, Durrani R, Potvin O, Duchesne S Hum Brain Mapp. 2024; 45(13):e70016.

PMID: 39254167 PMC: 11386326. DOI: 10.1002/hbm.70016.


Mild behavioral impairment domains are longitudinally associated with pTAU and metabolic biomarkers in dementia-free older adults.

Gonzalez-Bautista E, Mommeja M, de Mauleon A, Ismail Z, Vellas B, Delrieu J Alzheimers Dement. 2024; 20(7):4692-4701.

PMID: 38877658 PMC: 11247706. DOI: 10.1002/alz.13902.


References
1.
Nagy Z, Esiri M, Jobst K, Johnston C, Litchfield S, Sim E . Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience. 1995; 69(3):757-61. DOI: 10.1016/0306-4522(95)00331-c. View

2.
Liu Y, Paajanen T, Westman E, Zhang Y, Wahlund L, Simmons A . APOE ε2 allele is associated with larger regional cortical thicknesses and volumes. Dement Geriatr Cogn Disord. 2010; 30(3):229-37. DOI: 10.1159/000320136. View

3.
Marshall G, Fairbanks L, Tekin S, Vinters H, Cummings J . Neuropathologic correlates of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord. 2006; 21(3):144-7. DOI: 10.1159/000090674. View

4.
Ismail Z, McGirr A, Gill S, Hu S, Forkert N, Smith E . Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline. J Alzheimers Dis. 2021; 80(1):459-469. PMC: 8075401. DOI: 10.3233/JAD-201184. View

5.
Gharbi-Meliani A, Dugravot A, Sabia S, Regy M, Fayosse A, Schnitzler A . The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study. Alzheimers Res Ther. 2021; 13(1):5. PMC: 7784268. DOI: 10.1186/s13195-020-00740-0. View